Stock A174900 ABCLON INC.
Add to a list
To use this feature you must be a member
Log inSign up

News AbClon Inc.

Equities

A174900

KR7174900001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 23/05/2024 BST 		5-day change 1st Jan Change
19,550 KRW +13.27% Intraday chart for AbClon Inc. +22.65% +31.92%
2023 AbClon Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2023 AbClon Presents Non-Clon and Phase 1 Interim Results of its AT101 Novel CAR-T Therapy at the Annual 2023 AACR Conference CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alligator Bioscience’s Announces Henlius Biotech has Received FDA IND Clearance for Phase 3 Initiation to Evaluate HLX22 (AC101) in 1st Line HER2+ Advanced Gastric Cancer
AQ
AbClon Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
AbClon Presents Non-Clon and Phase 1 Interim Results of its AT101 Novel CAR-T Therapy at the Annual 2023 AACR Conference
CI
Alligator Bioscience Announces IND Approval for Second Phase 2 Clinical Trial of AC101 (HLX22) in Gastric Cancer developed by Shanghai Henlius Biotech in China
AQ
AbClon Inc. announced that it has received KRW 11.999976975 billion in funding from Quad Investment Management Corp.
CI
AbClon Inc. announced that it has received KRW 10 billion in funding from Quad Investment Management Corp.
CI
AbClon Inc. announced that it expects to receive KRW 11.999976975 billion in funding from Quad Investment Management Corp.
CI
AbClon Inc. announced that it expects to receive KRW 10 billion in funding from Quad Investment Management Corp.
CI
Alligator Bioscience : Announces First Patient Dosed in Phase II Clinical Trial with Shanghai Henlius Biotech, Inc. & AbClon, Inc.
AQ
AbClon Inc. announced that it has received KRW 13.999902624 billion in funding
CI
AbClon Inc. announced that it expects to receive KRW 13.999902624 billion in funding
CI
AbClon Inc.(KOSDAQ:A174900) added to S&P Global BMI Index
CI
AbClon Inc. has completed an IPO in the amount of KRW 6.80741 billion.
CI
AbClon Inc. has filed an IPO.
CI
AbClon Inc. has withdrawn its IPO.
CI
AbClon Inc. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A174900 Stock
  4. News AbClon Inc.